Trishula Therapeutics
PrivateLast Round
Spinoff
Aug 26, 2020
Company Overview
Trishula Therapeutics operates in Healthcare & Life Sciences and is based in South San Francisco, California. It was founded in 2020.
Trishula Therapeutics is a biotechnology company that develops cancer immunotherapies, specifically focusing on its first-in-class anti-CD39 antibody, TTX-030.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Trishula Therapeutics Comparables
Compare Trishula Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tizona Therapeutics | 91% | |
| Purinomia Biotech | 90% | |
| Arcus Biosciences | 83% |
For institutional investors. Book with your work email.
Trishula Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Trishula Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| InterWest Partners | Spinoff |
| Lightstone Ventures | Spinoff |
| MPM BioImpact | Spinoff |
| AbbVie Ventures | Spinoff |
| Abingworth | Spinoff |
| Canaan Partners | Spinoff |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 26, 2020
Raised a spinoff round with investors including Canaan Partners and AbbVie Ventures.
For institutional investors. Book with your work email.
Trishula Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Trishula Therapeutics's valuation, stock price, and market status.
Is Trishula Therapeutics a public or private company?
Trishula Therapeutics is a private company.
What is the current stock price of Trishula Therapeutics?
Trishula Therapeutics is a private company, so its shares have no public market price. Caplight tracks Trishula Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Trishula Therapeutics worth (valuation)?
Valuation information for Trishula Therapeutics is not publicly available.
Can I buy Trishula Therapeutics stock?
Trishula Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Trishula Therapeutics's last funding round?
Trishula Therapeutics's most recent funding round was Spinoff on August 26, 2020.
Who are the main investors in Trishula Therapeutics?
Key investors in Trishula Therapeutics include InterWest Partners, Lightstone Ventures, MPM BioImpact, AbbVie Ventures, Abingworth.
Will Trishula Therapeutics IPO soon?
No public IPO plans have been announced for Trishula Therapeutics.
How can I track Trishula Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Trishula Therapeutics's shares on secondary markets.